| Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine T Patalon, Y Saciuk, A Peretz, G Perez, Y Lurie, Y Maor, S Gazit Nature Communications 13 (1), 3203, 2022 | 137 | 2022 |
| Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control … S Gazit, Y Saciuk, G Perez, A Peretz, VE Pitzer, T Patalon bmj 377, 2022 | 94 | 2022 |
| Effectiveness of a third dose of BNT162b2 mRNA vaccine Y Saciuk, J Kertes, N Shamir Stein, A Ekka Zohar The Journal of infectious diseases 225 (1), 30-33, 2022 | 87 | 2022 |
| Pfizer-BioNTech vaccine effectiveness against Sars-Cov-2 infection: Findings from a large observational study in Israel Y Saciuk, J Kertes, M Mandel, B Hemo, NS Stein, AE Zohar Preventive Medicine 155, 106947, 2022 | 47 | 2022 |
| Effectiveness of mRNA BNT162b2 vaccine 6 months after vaccination among patients in large health maintenance organization, Israel J Kertes, SB Gez, Y Saciuk, L Supino-Rosin, NS Stein, M Mizrahi-Reuveni, ... Emerging infectious diseases 28 (2), 338, 2022 | 41 | 2022 |
| Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target … S Gazit, Y Saciuk, G Perez, A Peretz, A Ben-Tov, EA Stuart, T Patalon The Lancet Microbe 4 (7), e495-e505, 2023 | 16 | 2023 |
| Dynamics of naturally acquired immunity against severe acute respiratory syndrome coronavirus 2 in children and adolescents T Patalon, Y Saciuk, G Perez, A Peretz, A Ben-Tov, S Gazit The Journal of Pediatrics 257, 113371, 2023 | 11 | 2023 |
| An outbreak of parvovirus B19 in Israel T Patalon, Y Saciuk, D Trotzky, G Pachys, A Ben-Tov, Y Segal, S Gazit Viruses 15 (11), 2261, 2023 | 8 | 2023 |
| Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine. Nat Commun. 2022; 13: 3203 T Patalon, Y Saciuk, A Peretz, G Perez, Y Lurie, Y Maor, S Gazit | 8 | |
| Naturally-acquired immunity dynamics against SARS-CoV-2 in children and adolescents T Patalon, Y Saciuk, H Ohayon Hadad, G Perez, A Peretz, A Ben-Tov, ... medRxiv, 2022.06. 20.22276650, 2022 | 5 | 2022 |
| COVID‐19 Vaccine Effectiveness and the Evidence on Boosters: A Systematic Review (with Partial Evidence on the Omicron Variant) BS Black, D Thaw Northwestern Law & Econ Research Paper, 21-57, 2023 | 4 | 2023 |
| Effectiveness of the mRNA BNT162b2 vaccine six months after vaccination: findings from a large Israeli HMO. medRxiv J Kertes, S Baruch Gez, Y Saciuk Published online 10, 1, 2021 | 3 | 2021 |
| Coping with Conflict: Short-Term Anxiolytic Medication Use Amidst National Stress in Israel T Patalon, Y Saciuk, Y Yonatan, M Hoshen, D Trotzky, G Pachys, ... medRxiv, 2024.10. 04.24314902, 2024 | | 2024 |
| Allergic to Confounding: Leveraging Penicillin Allergy as an Instrumental Variable to Estimate the Causal Effect of Antibiotic Use on Resistance Y Saciuk, D Nevo, M Chowers, U Obolski medRxiv, 2024.08. 19.24312204, 2024 | | 2024 |
| Mpox Patient Journey in Israel T Patalon, G Perez, Y Saciuk, Z Refaeli, S Gazit Microorganisms 11 (4), 1042, 2023 | | 2023 |
| Waning Effectiveness of the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine (preprint) T Patalon, Y Saciuk, A Peretz, G Perez, Y Lurie, Y Maor, S Gazit | | 2022 |
| Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel (preprint) S Gazit, Y Saciuk, G Perez, A Peretz, V Pitzer, T Patalon | | 2022 |
| Pfizer-BioNTech Vaccine Effectiveness Against SARS-CoV-2 Infection: Findings From a Large Observational Study in Israel (preprint) Y Saciuk, J Kertes, M Mandel, B Hemo, NS Stein, AE Zohar | | 2021 |
